Chengdu

688319.SS

Tags: CN Healthcare Biotechnology

Chengdu Olymvax Biopharmaceuticals Inc. Price (688319.SS)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

405,440,226

(0.0432)%

Market Cap of Chengdu (688319.SS)

Market cap:

As of , 688319.SS has a market cap of . This makes 688319.SS the 2332th most valuable company in the CN by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Olymvax Biopharmaceuticals Inc. develops and supplies vaccines. The company offers vaccines for Tetanus, a deadly infectious disease that causes nervous system toxicity by toxigenic clostridium tetanus; and haemophilus influenzae type b. it also develops vaccines for Staphylococcus aureus, a pathogenic bacterium that causes hospital infection and community infection; and Group A streptococcus disease. The company was founded in 2009 and is based in Chengdu, China. Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $7.06-16.15
Market Cap 5.99B
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Biotechnology

ceo: Mr. Shaowen Fan
IPO Date: June, 08, 2021
Country: CN
Currency: CNY
Headquaters: No Data
Employees: 471

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: